NEFL and myeloid sarcoma: Serum and CSF NFL concentrations were significantly higher in patients with MS than in HCs (p < 0.001 and p < 0.001, respectively) and in controls with noninflammatory neurologic disease and symptomatic controls (p < 0.001 and p < 0.001, respectively).